Joyce, Jeffrey - Florida State University - Department of Biomedical Sciences

个人简介

Dr. Joyce has been engaged in biomedical research, graduate education and research administration for more than 30 years. He has been a leader in interdisciplinary research programs at the University of Pennsylvania School of Medicine (Philadelphia) and Sun Health Research Institute (Sun City, Ariz.), where he served as associate director of Sun Health Research Institute, and senior scientist for the Thomas H. Christopher Parkinson’s Disease Research Center. He also directed a center without walls for Parkinson’s disease research. In 2007 he established the Division of Research at Maricopa Integrated Health System in Phoenix, where he served as director until 2012. He also was appointed research professor of neurology and psychiatry at the University of Arizona College of Medicine-Phoenix and associate professor in the School of Biological and Health Systems Engineering at Arizona State University (Tempe). In 2012 Dr. Joyce began serving as vice president for research and professor of pharmacology at Kansas City University. He assumed the role of senior associate dean for research and graduate programs in the College of Medicine at FSU in 2017.

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Joyce, Jeffrey N. Developing a Sustainable Research Culture in an Independent Academic Medical Center. Journal of Research Administration [society publication of SRA International], 2013, Vol 44, No. 1, Pages 75-90. Joyce, Jeffrey N. Regulatory compliance for research in an academic medical center. Compliance Today [Health Care Compliance Association monthly], Vol. 13, No. 12, Pages 29- 37, December 2011. Joyce, Jeffrey N. and Millan, M.J. Dopamine D3 receptor agonists for protection and repair in Parkinson's disease. Current Opinion in Pharmacology 2007, 7:100–105. Joyce, Jeffrey N. and Millan, M.J. Dopamine D3 receptor antagonists as therapeutic agents. Drug Discov Today. 2005 10(13):917-25. Joyce, Jeffrey N. (2001) Dopamine D3 receptor as a therapeutic target for antipsychotic and antiparkinsonian Drugs. Pharmacology & Therapeutics 90(2-3):231-259. Joyce, Jeffrey N. and Meador-Wooodruff, J.H. Linking the family of D2 receptors to neuronal circuits in human brain: insights into schizophrenia. Neuropsychopharmacol. 16:375-384,1997.